Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors. Its structure supports enhanced metabolic stability and improved binding affinity in drug candidates. Also employed in the preparation of agrochemicals and bioactive molecules where fluorine substitution influences potency and pharmacokinetics. Suitable for use in peptide coupling and heterocyclic synthesis due to the presence of both amino and carboxylic acid functional groups.